Amylyx Pharmaceuticals (AMLX) Shares Issued (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Shares Issued of $11.4 million for Q1 2026, up 18.93% year-over-year from $9.6 million in Q1 2025, and up 21.62% quarter-over-quarter from $9.4 million in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Shares Issued (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Shares Issued history runs 6 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- In Q1 2026, Shares Issued rose 18.93% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 18.93% YoY), while the FY2025 annual figure was $9.4 million, up 21.73% from the prior year.
- Shares Issued for Q1 2026 stood at $11.4 million, up from $9.4 million in the prior quarter.
- The five-year high for Shares Issued was $11.4 million in Q1 2026, with the low at $1.8 million in Q1 2022.
- The 5-year median for Shares Issued is $8.5 million (2022), against an average of $7.7 million.
- Peak annual rise in Shares Issued reached 467.66% in 2023, while the deepest fall reached 62.8% in 2023.
- Amylyx Pharmaceuticals' Shares Issued stood at $8.5 million in 2022, then climbed by 15.83% to $9.8 million in 2023, then fell by 21.32% to $7.7 million in 2024, then climbed by 21.73% to $9.4 million in 2025, then climbed by 21.62% to $11.4 million in 2026.
- Business Quant data shows AMLX's Shares Issued at $11.4 million in Q1 2026, $9.4 million in Q4 2025, and $9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.34 Bn | 4.34 Bn | - | 11.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.33 Mn |
| Jun 30, 2026 | 11.33 Mn |
| Mar 31, 2026 | 11.44 Mn |
| Mar 31, 2026 | 11.44 Mn |
| Dec 31, 2025 | 9.41 Mn |
| Dec 31, 2025 | 9.41 Mn |
| Sep 30, 2025 | 9.60 Mn |
| Sep 30, 2025 | 9.60 Mn |
| Jun 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 4.87 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 8.34 Mn |
| Sep 30, 2024 | 8.34 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.74 Mn |